IRE1 RNase blockade in cDC1 equivalents from FLT3-L-containing cultures resulted in lower expressions of surface MHC Class I/ peptide complexes and reduced IL-12 production upon recognition of tumor cell lysates, which accompanied the reduced cross-presentation abilities [106]. The gene discussed is ERN1; the disease is neoplasm.